159 related articles for article (PubMed ID: 38284258)
1. [Research progress of interaction between CAFs and M2 macrophages to promote tumor progression].
Wu J; Zhang Q; Yang Z; Zhang R; Zhang J; Zeng Z; Wu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):168-173. PubMed ID: 38284258
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast.
Nakamura Y; Kinoshita J; Yamaguchi T; Aoki T; Saito H; Hamabe-Horiike T; Harada S; Nomura S; Inaki N; Fushida S
Gastric Cancer; 2022 May; 25(3):515-526. PubMed ID: 34997450
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
4. CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression.
Wu J; Liu X; Wu J; Lou C; Zhang Q; Chen H; Yang Z; Long S; Wang Y; Shang Z; Hu Z; Zhang R; Zhang J; Zeng Z
Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166521. PubMed ID: 35985448
[TBL] [Abstract][Full Text] [Related]
5. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
7. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
[TBL] [Abstract][Full Text] [Related]
8. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
Suzuki J; Tsuboi M; Ishii G
Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
[TBL] [Abstract][Full Text] [Related]
10. GPR30 knockdown weakens the capacity of CAF in promoting prostate cancer cell invasion via reducing macrophage infiltration and M2 polarization.
Zhang R; Zong J; Peng Y; Shi J; Du X; Liu H; Shen Y; Cao J; Jia B; Liu F; Zhang J
J Cell Biochem; 2021 May; ():. PubMed ID: 33938030
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
12. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
13. CAFs secrete CXCL12 to accelerate the progression and cisplatin resistance of colorectal cancer through promoting M2 polarization of macrophages.
Jiang H; Ge H; Shi Y; Yuan F; Yue H
Med Oncol; 2023 Feb; 40(3):90. PubMed ID: 36737590
[TBL] [Abstract][Full Text] [Related]
14. Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages.
Stadler M; Pudelko K; Biermeier A; Walterskirchen N; Gaigneaux A; Weindorfer C; Harrer N; Klett H; Hengstschläger M; Schüler J; Sommergruber W; Oehler R; Bergmann M; Letellier E; Dolznig H
Cancer Lett; 2021 Nov; 520():184-200. PubMed ID: 34256095
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
16. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
17. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
18. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
[TBL] [Abstract][Full Text] [Related]
19. Identifying potential targets for lung cancer intervention by analyzing the crosstalk of cancer-associated fibroblasts and immune and metabolism microenvironment.
Wei S; Bao M; Zhu Y; Zhang W; Jiang L
Environ Toxicol; 2023 Aug; 38(8):1951-1967. PubMed ID: 37186041
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
Xiao Y; Wang Z; Gu M; Wei P; Wang X; Li W
Clin Exp Med; 2024 Jun; 24(1):126. PubMed ID: 38864912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]